Rationale for universal WBC reduction of blood components? [5]

Transfusion

Volumn 40, Issue 3, 2000, Pages 389-

  Pittman, D L ^a  

^a Professional Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD COMPONENT THERAPY; BLOOD TRANSFUSION REACTION; COST; FEVER; FOOD AND DRUG ADMINISTRATION; IMMUNOMODULATION; LETTER; LEUKOCYTE; REDUCTION; THROMBOCYTE TRANSFUSION;

EID: 0034104690     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2000.40030389.x     Document Type: Letter

References (2)

1. 1 Miller JP, AuBuchon JP. Leukocyte‐reduced and cytomegalovirus‐reduced‐risk blood components. In: Mintz PD, ed. Transfusion therapy: clinical principles and practice. Bethesda: AABB Press, 1999: 313–39.
2. 2 Blajchman MA. Transfusion‐associated immunomodu‐lation and universal white cell reduction: are we putting the cart before the horse? (editorial). Transfusion 1999 ; 39: 665–70.